Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 757

3.

Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.

Ruan XY, Jin FY, Liu YL, Peng ZL, Sun YG.

Chin Med J (Engl). 2008 Jul 5;121(13):1155-8.

PMID:
18710630
4.

Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.

Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.

Menopause. 2013 Jan;20(1):72-8. doi: 10.1097/gme.0b013e31825fe2e8.

PMID:
22968256
5.

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.

McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.

Bone. 2007 Jul;41(1):122-8. Epub 2007 Mar 24.

PMID:
17468062
6.

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.

Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ, Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W.

Bone. 1996 Feb;18(2):141-50. Erratum in: Bone 1996 Jul;19(1):78.

PMID:
8833208
7.

Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.

Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Bianchi G.

Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.

PMID:
19075192
8.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
9.

Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2007 May;55(5):752-7.

PMID:
17493196
10.
11.
12.

Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women.

Stock JL, Bell NH, Chesnut CH 3rd, Ensrud KE, Genant HK, Harris ST, McClung MR, Singer FR, Yood RA, Pryor-Tillotson S, Wei L, Santora AC 2nd.

Am J Med. 1997 Oct;103(4):291-7.

PMID:
9382121
13.
14.

Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis.

Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Montagnani A, Monaco R, Gennari C.

Calcif Tissue Int. 1999 Nov;65(5):359-64.

PMID:
10541760
15.
16.

Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial.

Keegan TH, Schwartz AV, Bauer DC, Sellmeyer DE, Kelsey JL; fracture intervention trial.

Diabetes Care. 2004 Jul;27(7):1547-53.

PMID:
15220226
17.

Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.

Iwamoto J, Takeda T, Ichimura S, Uzawa M.

Keio J Med. 2003 Jun;52(2):113-9.

18.

A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.

Rogers A, Glover SJ, Eastell R.

Bone. 2009 Dec;45(6):1044-52. doi: 10.1016/j.bone.2009.07.089. Epub 2009 Aug 7.

PMID:
19665601
19.

Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures.

Minisola S, Pacitti MT, Ombricolo E, Costa G, Scarda A, Palombo E, Rosso R.

Maturitas. 1998 Jun 17;29(3):265-70.

PMID:
9699199
20.

Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women.

Tseng LN, Sheu WH, Ho ES, Lan HH, Hu CC, Kao CH.

Metabolism. 2006 Jun;55(6):741-7.

PMID:
16713432

Supplemental Content

Support Center